Here are five things to know:
1. This cut is part of an effort to remove $1 billion in annual costs in the business that makes sterilization equipment and surgical tools.
2. The eliminated positions represent 2.5 percent of Johnson & Johnson’s global workforce and up to 6 percent of its medical device segment.
3. Johnson & Johnson’s medical device sales have been struggling lately, with sales slipping 2.9 percent in the first nine months of the year and 2.4 percent in the United States.
4. The moves relate to Johnson & Johnson’s orthopedic, surgery and cardiovascular businesses.
5. The company said the restructuring won’t affect its consumer medical devices businesses, vision care and diabetes care businesses.
More articles on devices and implants:
SeaSpine, K2M, Smith & Nephew & more: 19 key notes
DeGen Medical launches Hyper-C Anterior Cervical Plate System: 4 key notes
Medical Compression Systems seeks buyer: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.